Evaluation of antibody response after COVID‐19 vaccination of healthcare workers
Author:
Affiliation:
1. Department of Medical Microbiology Alanya Alaaddin Keykubat University, School of Medicine Alanya Antalya Turkey
2. Alanya Alaaddin Keykubat University, Education and Research Hospital Alanya Antalya Turkey
Publisher
Wiley
Subject
Infectious Diseases,Virology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27420
Reference31 articles.
1. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
2. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
3. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients
4. Antibody response to Covıd‐19 infectıon clinical variables at play;Parkash A;medRxiv
5. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects;Current Pharmaceutical Biotechnology;2024-10
2. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination;Virology Journal;2024-06-13
3. Immunological Insights: A Multicenter Longitudinal Study on Humoral Response to COVID-19 Vaccines in Greece;Acta Microbiologica Hellenica;2024-06-05
4. Evaluating length of immune response to SARS-CoV2 vaccine: A cohort review of spike protein antibody titer after vaccination;Clinical Immunology Communications;2024-06
5. Relationship of various COVID-19 antibody titer with individual characteristics and prediction of future epidemic trend in Xiamen City, China;Journal of Thoracic Disease;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3